Descending serotonergic pain inhibitory pathway

The descending serotonergic pain inhibitory pathway is a fundamental component of the endogenous pain modulation system, originating primarily in the rostral ventromedial medulla (RVM) and projecting to the spinal cord dorsal horn (StatPearls, NBK539789). This pathway regulates the transmission of nociceptive signals by releasing serotonin (5-HT), which interacts with various receptor subtypes to either inhibit or facilitate pain (PubMed, 12445014). Specifically, activation of 5-HT1A and 5-HT7 receptors in the spinal cord is associated with antinociception, while 5-HT3 receptors can promote pro-nociceptive effects (Nature Reviews Neuroscience, 10.1038/nrn2767). Dysfunction or unmasking of this pathway is a key mechanism in the development of chronic pain states, such as neuropathic pain and fibromyalgia, where the balance of descending control shifts toward facilitation (PubMed, 20167330). Pharmacological agents like serotonin-norepinephrine reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs) target this system by increasing synaptic 5-HT levels, thereby enhancing the inhibitory influence on spinal pain processing (PubMed, 24734457).

Other names

Descending serotonergic systemDescending pain modulation systemBulbo-spinal serotonergic pathwayEndogenous serotonergic inhibitory control

Enhancement of descending inhibitory tone through the inhibition of serotonin reuptake in the spinal cord dorsal horn.